But all drugs have their risks, and GLP-1s are no exception
Scientists are studying their effects on fatty liver disease (NAFLD and NASH), polycystic ovary syndrome (PCOS), addiction and impulse-control disorders, neurodegenerative diseases, and inflammatory bowel disease
Doctors and patients alike are increasingly exploring how fractional doses can target specific metabolic and inflammatory issues without the intensity of a full weight-loss regimen
For more ideas, read what to eat when you are not hungry on GLP-1
With proper guidance and understanding from clinics that facilitate Mounjaro prescriptions, you can make informed decisions aligning with your health goals
Kidney Impairment Semaglutide base requires caution in patients with kidney disease